Indapta Therapeutics Inc.

CIK 1910175 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Indapta Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Oct 14, 2025D0001910175-25-000003
Feb 10, 2022D0001910175-22-000001